The market for Neuroprotection is expected to grow at steady growth rate during the forecast period largely attributed due to increasing drug development in the pharmaceutical and biotechnology industry along with increasing patient population pool, growing incidences of CNS diseases, increasing awareness, increased demand for more target specific drug treatment for Neurodegenerative diseases along with favorable government regulations. The other factors responsible for the growth the market include increasing healthcare infrastructure, increasing economic stability in developing economies, increasing participation of major market players in in developing economies such as Latin America and Middle East & Africa. The North America region in Neuroprotection market is anticipated to hold major market share along with Europe region during the forecast period. The region are expected to grow moderately in comparison to Asia Pacific region during the forecast period whereas, primarily due to the effect of pricing pressure due to increased competition among leading brands, increase of generic products and growing number of regional players who are able to provide products at much lower prices. However, new product launch and robust pipeline are expected to enter Neuroprotection market, which are likely to increase future growth and demand of the Neuroprotection.
Get Report Sample @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=40553
Increasing prevalence of neurodegenerative diseases
Neuroprotection is the property of drugs which are used in prevention of neuronal degradation by deterring one or more than one pathophysiological phases in the progressions which follow brain ischemia due to occlusion of a cerebral artery or neurodegenerative processes. These neuroprotective agents play an important role in the management of neurodegenerative diseases as well as in central nervous system trauma, cerebral ischemia, and other conditions.
Rapid increase in pharmaceutical sector and increasing patient population has led to an increased demand for neuroprotective drugs as they prove to be highly efficient in treatment of neurodegenerative diseases such as Alzheimer’s, Parkinson’s, Macular Sclerosis ,and other diseases where neural damage takes place. These drivers along with increasing incidences of traumatic brain injury are expected to drive the Neuroprotection market during the forecast period.
For instance, TBI is a contributing factor to a third (30%) of all injury-related deaths in the U.S.
The free radical trapping agent product expected to dominate the neuroprotection market
The global Neuroprotection market has been segmented into product, application, and region. On the basis of product the Neuroprotection market has been further segmented as; Free Radical Trapping Agents (Antioxidants), Glutamate Antagonists (Anti-Excitotoxic Agents), Apoptosis Inhibitors, Anti-inflammatory Agents, Neurotrophic Factors (NTFs), Metal Ion Chelators, Stimulants, and Others. During the forecast period 2017-2025 the free radical trapping agents (antioxidants) is expected to expand at a higher rate of CAGR to reach a market value of approximately US$ 18,000.0 Mn by 2025.The free radical trapping agent product held major share in Neuroprotection market in 2016, the segment is expected to continue its strong hold in neuroprotection market during the forecast period. Increasing drug discovery and product launch is anticipated to drive the Neuroprotection market growth during the forecast period.